GlassScriptPhysician profile
Ganesh K Kartha
NPI 1861718553
$11,427.77
in general payments reported to CMS, 2019-2025
51 companies · $2,337 in 2025
The $2,337 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $591 · 2021: $1,522 · 2022: $2,112 · 2023: $1,975 · 2024: $2,200 · 2025: $2,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,451 · Education: $45.93 · Entertainment: $15.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,451.08 |
| Education | $45.93 |
| Entertainment | $15.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,644.57 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $645.56 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic USA, INC. | $598.49 | 2019-2020 | |
| Urogen Pharma, INC. | $586.38 | 2021-2025 | Jelmyto |
| Boston Scientific Corporation | $541.41 | 2019-2023 | Ams 700, Rezum Generator |
| Janssen Biotech, INC. | $522.21 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $469.28 | 2020-2024 | Prolaris |
| Teleflex LLC | $422.48 | 2020-2024 | Urolift |
| Merck Sharp & Dohme LLC | $291.99 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Verity Pharmaceuticals INC. | $277.68 | 2024-2025 | Trelstar, Tlando |
| Antares Pharma, INC. | $274.88 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Accord Healthcare, INC. | $243.64 | 2023-2025 | |
| Blue Earth Diagnostics | $240.15 | 2019-2021 | |
| Astellas Pharma US INC | $232.89 | 2019-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $227.94 | 2022-2024 | Xiaflex, Aveed |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $224.38 | 2021-2024 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $179.87 | 2019-2025 | |
| Pfizer INC. | $165.91 | 2023-2024 | |
| Urovant Sciences INC | $165.62 | 2021-2022 | |
| Stryker Corporation | $143.54 | 2024 | 1788 |
| Olympus America INC. | $129.05 | 2025 | Itind System |
| Sanara Medtech INC. | $127.27 | 2025 | Celleraterx |
| Ferring Pharmaceuticals INC. | $121.80 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $116.80 | 2025 | Cvac Aspiration System |
| Bioventus LLC | $110.10 | 2023 | |
| Endo USA, INC. | $65.20 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $62.31 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $57.17 | 2023-2024 | Pylarify |
| Astrazeneca Pharmaceuticals LP | $54.66 | 2025 | Imfinzi, Lynparza |
| Amgen INC. | $51.03 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $48.75 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $36.09 | 2020-2021 | |
| Telix Pharmaceuticals | $34.32 | 2024 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $34.32 | 2021-2025 | |
| Hollister Incorporated | $32.74 | 2021 | |
| Allergan, INC. | $28.67 | 2021 | |
| Coloplast Corp | $26.51 | 2019-2020 | |
| Zyla Life Sciences, INC. | $26.15 | 2019-2020 | |
| Conmed Corporation | $16.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.43 | 2022 | |
| Provepharm INC. | $15.43 | 2024 | Bludigo |
| Paragon 28, INC. | $14.45 | 2020 | |
| Myovant Sciences INC. | $14.18 | 2022 | |
| Intuitive Surgical, INC. | $13.88 | 2023-2025 | |
| Avanos Medical | $13.66 | 2019 | |
| Srs Medical Systems, INC. | $12.84 | 2023 | Urocuff |
| Kowa Pharmaceuticals America, INC. | $12.76 | 2022 | |
| Baudax Bio INC. | $11.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.90 | 2020 | |
| Organon LLC | $11.72 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,770.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ganesh Kartha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.